Search

Tamra Dicus

Examiner (ID: 15495, Phone: (571)272-1519 , Office: P/1791 )

Most Active Art Unit
1791
Art Unit(s)
1781, 1775, 1794, 1791, 1785, 1787, 1774
Total Applications
1075
Issued Applications
293
Pending Applications
132
Abandoned Applications
655

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20484987 [patent_doc_number] => 20260021185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-22 [patent_title] => LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE [patent_app_type] => utility [patent_app_number] => 19/345876 [patent_app_country] => US [patent_app_date] => 2025-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19345876 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/345876
LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE Sep 29, 2025 Pending
Array ( [id] => 20497588 [patent_doc_number] => 20260027045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-29 [patent_title] => METHODS OF ADMINISTERING ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 19/277509 [patent_app_country] => US [patent_app_date] => 2025-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18766 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19277509 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/277509
METHODS OF ADMINISTERING ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS Jul 22, 2025 Pending
Array ( [id] => 20484849 [patent_doc_number] => 20260021047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-22 [patent_title] => ORAL FORMULATIONS OF DEURUXOLITINIB [patent_app_type] => utility [patent_app_number] => 19/273752 [patent_app_country] => US [patent_app_date] => 2025-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7865 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19273752 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/273752
ORAL FORMULATIONS OF DEURUXOLITINIB Jul 17, 2025 Pending
Array ( [id] => 20287239 [patent_doc_number] => 20250312482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-09 [patent_title] => LIPID NANOPARTICLES FOR THE TREATMENT OF VASCULAR DISEASES [patent_app_type] => utility [patent_app_number] => 19/171160 [patent_app_country] => US [patent_app_date] => 2025-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14141 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19171160 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/171160
LIPID NANOPARTICLES FOR THE TREATMENT OF VASCULAR DISEASES Apr 3, 2025 Pending
Array ( [id] => 19989535 [patent_doc_number] => 20250127757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-24 [patent_title] => COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 19/005427 [patent_app_country] => US [patent_app_date] => 2024-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57574 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19005427 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/005427
COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME Dec 29, 2024 Pending
Array ( [id] => 19996634 [patent_doc_number] => 20250134856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-01 [patent_title] => COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 19/005376 [patent_app_country] => US [patent_app_date] => 2024-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57541 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19005376 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/005376
COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME Dec 29, 2024 Abandoned
Array ( [id] => 19989534 [patent_doc_number] => 20250127756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-24 [patent_title] => COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 19/005409 [patent_app_country] => US [patent_app_date] => 2024-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57820 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19005409 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/005409
COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME Dec 29, 2024 Pending
Array ( [id] => 19752871 [patent_doc_number] => 20250041436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells [patent_app_type] => utility [patent_app_number] => 18/904575 [patent_app_country] => US [patent_app_date] => 2024-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29797 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18904575 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/904575
Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells Oct 1, 2024 Pending
Array ( [id] => 19629829 [patent_doc_number] => 20240408278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => RAPID FORMING ARTIFICIAL BLOOD VESSEL AND PREPARATION METHOD [patent_app_type] => utility [patent_app_number] => 18/812148 [patent_app_country] => US [patent_app_date] => 2024-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18812148 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/812148
RAPID FORMING ARTIFICIAL BLOOD VESSEL AND PREPARATION METHOD Aug 21, 2024 Abandoned
Array ( [id] => 19570312 [patent_doc_number] => 20240374604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => CANCER TREATMENTS USING COMBINATIONS OF CDK AND ERK INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/787389 [patent_app_country] => US [patent_app_date] => 2024-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14378 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18787389 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/787389
CANCER TREATMENTS USING COMBINATIONS OF CDK AND ERK INHIBITORS Jul 28, 2024 Pending
Array ( [id] => 19707924 [patent_doc_number] => 20250018066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => Ophthalmic dye composition [patent_app_type] => utility [patent_app_number] => 18/772309 [patent_app_country] => US [patent_app_date] => 2024-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5760 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18772309 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/772309
Ophthalmic dye composition Jul 14, 2024 Pending
Array ( [id] => 19784310 [patent_doc_number] => 20250057989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => TMEM-MCD IN THE MINIMALLY INVASIVE ASSESSMENT OF THE ACTIVITY STATUS OF TMEM IN ITS DISSEMINATION OF TUMOR CELLS [patent_app_type] => utility [patent_app_number] => 18/766083 [patent_app_country] => US [patent_app_date] => 2024-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5617 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18766083 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/766083
TMEM-MCD IN THE MINIMALLY INVASIVE ASSESSMENT OF THE ACTIVITY STATUS OF TMEM IN ITS DISSEMINATION OF TUMOR CELLS Jul 7, 2024 Pending
Array ( [id] => 19784316 [patent_doc_number] => 20250057995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => RADIOLIGANDS FOR IMAGING THE LPA1 RECEPTOR [patent_app_type] => utility [patent_app_number] => 18/732745 [patent_app_country] => US [patent_app_date] => 2024-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18732745 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/732745
RADIOLIGANDS FOR IMAGING THE LPA1 RECEPTOR Jun 3, 2024 Abandoned
Array ( [id] => 19830177 [patent_doc_number] => 20250081963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => ANTIMICROBIAL AND DRUG-NEUTRALIZING COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/640861 [patent_app_country] => US [patent_app_date] => 2024-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13193 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640861 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/640861
ANTIMICROBIAL AND DRUG-NEUTRALIZING COMPOSITION Apr 18, 2024 Pending
Array ( [id] => 19656137 [patent_doc_number] => 20240423202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => ANTIMICROBIAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/624853 [patent_app_country] => US [patent_app_date] => 2024-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8869 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18624853 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/624853
ANTIMICROBIAL COMPOSITION Apr 1, 2024 Abandoned
Array ( [id] => 20505017 [patent_doc_number] => 12539279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-03 [patent_title] => Supramolecular ionizable lipid molecules with heteroatomic tuning for nucleic acid delivery [patent_app_type] => utility [patent_app_number] => 18/621526 [patent_app_country] => US [patent_app_date] => 2024-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19234 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18621526 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/621526
Supramolecular ionizable lipid molecules with heteroatomic tuning for nucleic acid delivery Mar 28, 2024 Issued
Array ( [id] => 19402066 [patent_doc_number] => 20240285577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 18/611564 [patent_app_country] => US [patent_app_date] => 2024-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62327 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18611564 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/611564
COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME Mar 19, 2024 Pending
Array ( [id] => 19263496 [patent_doc_number] => 20240207193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => CHEMICAL COMPOSITION FOR ENTERIC DRUG DELIVERY [patent_app_type] => utility [patent_app_number] => 18/600459 [patent_app_country] => US [patent_app_date] => 2024-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4973 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18600459 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/600459
CHEMICAL COMPOSITION FOR ENTERIC DRUG DELIVERY Mar 7, 2024 Pending
Array ( [id] => 19263719 [patent_doc_number] => 20240207416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => STEREOCOMPLEX OF OLIGOLACTIC ACID CONJUGATES IN MICELLES FOR IMPROVED PHYSICAL STABILITY AND ENHANCED ANTITUMOR EFFICACY [patent_app_type] => utility [patent_app_number] => 18/424697 [patent_app_country] => US [patent_app_date] => 2024-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10459 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18424697 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/424697
STEREOCOMPLEX OF OLIGOLACTIC ACID CONJUGATES IN MICELLES FOR IMPROVED PHYSICAL STABILITY AND ENHANCED ANTITUMOR EFFICACY Jan 25, 2024 Pending
Array ( [id] => 19280098 [patent_doc_number] => 20240216571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => CHITOSAN SUPERFINE FIBER SYSTEMS [patent_app_type] => utility [patent_app_number] => 18/415412 [patent_app_country] => US [patent_app_date] => 2024-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13411 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18415412 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/415412
CHITOSAN SUPERFINE FIBER SYSTEMS Jan 16, 2024 Pending
Menu